You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Sentieon will integrate its DNAseq and TNseq variant-calling technology into Qiagen's CLC Genomics Workbench and the Qiagen Clinical Insight platform.
Genome Canada and its partners recently funded two new initiatives with C$255 that will back precision medicine, genomics, and technology development.
In the longer term, the two firms plan to use PlexBio's multiplexing technology to develop a full menu of infectious disease assays.
Datavant, a fledgling spinoff from Roivant Sciences, is trying to break down information silos that often lead to poorly designed clinical trials.
Google expects its newly released open-source update to DeepVariant to improve the accuracy of variant calling, particularly in plant and animal genomes.
In healthcare, Cloudera has evolved from mostly supporting downstream variant stores to being a centerpiece of the shift to GATK4.
Fresh out of Techstars, two of the creators of the rapidly adopted genomic analysis platform Nextflow have big plans for their fledgling company, Lifebit.
After more than two years of development, the British vendor has matched HPC for sequencing alignment accuracy, at far lower power consumption.
The collaboration will leverage DiaSorin's Liaion MDX PCR system, and Tecan's Fluent Laboratory Automation Solution to provide users a complete sample-to-result system.
The new algorithm, called TOPSPIN, complements the company's MMprofiler test. It is considering making TOPSPIN-generated data available to its MMprofiler patients.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.